Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |

Emgality is used in preventive treatment of migraine in adults. It contain active ingredient was Galcanezumab-GNLM. Strength of copiktra was 120 mg/ml injectable.It is approved by an FDA 27/09/2018. For more details click here. Read More »

Copiktra is used in treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma. It contain active ingredient was Duvelisib. Strength of copiktra was 15 mg and 25 mg. it is approved by an FDA 24/09/2018.It is available capsule. For more details click here. Read More »

Ajovy is used in treatment of migraine in adults. It contain active ingredient was Fremanezumab-Vfrm. Strength of ajovy was 150 mg/ml. It is available in injection forms. It approved by FDA 14/09/208. For more details click here. Read More »

PIFELTRO is a new medicine for the treatment of HIV-1 infection in adults who have not taken HIV-1 medicines before. HIV-1 causes AIDS, PIFELTRO is a tablet that is taken by month once a day in combination with other drugs approved for the treatment of HIV-1 infection. It can reduce viral load when compare to other approved drugs for HIV-1. ... Read More »

Lumoxiti injection is a new medicine for intravenous use for the treatment of adult patients with refractory hairy cell leukemia (HCL) who have received minimum two prior systemic therapies, including treatment with a purine nucleoside analog. Lumoxiti is a CD22-directed cytotoxin and very first drug of this type of treatment for patients with HCL. It is rare and slow growing ... Read More »